Annals of Hematology

Papers
(The H4-Index of Annals of Hematology is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
A case of acute promyelocytic leukemia with pericardial effusion successfully managed with colchicine during ATO administration63
Concomitant multiple sclerosis and polycythemia vera successfully treated with glatiramer acetate53
A new case of Bicêtre hemoglobin in an adult male: clinical observations over a period of four years50
Refractory hepatosplenic T-cell lymphoma was successfully treated with salvage allogeneic hematopoietic stem cell transplantation combined with enhanced myeloablative preconditioning46
Trimethoprim-sulfamethoxazole prevents interstitial pneumonitis in B-cell lymphoma patients receiving chemotherapy: a propensity score matching analysis44
Real-life use of mTOR inhibitor-based therapy in adults with autoimmune cytopenia highlights strong efficacy in relapsing/refractory multi-lineage autoimmune cytopenia41
Efficacy and safety of olverembatinib as maintenance therapy after allogeneic hematopoietic cell transplantation in Philadelphia chromosome–positive acute lymphoblastic leukemia39
Correction to: Hemophagocytic lymphohistiocytosis in HIV-associated lymphoproliferative disorders39
Prognostic impact of TET2 mutations in patients with acute myeloid leukemia: HM-SCREEN-Japan 01 and 02 study38
Causes of death and treatment-related mortality in newly diagnosed childhood acute lymphoblastic leukemia treatment with Chinese Children’s Cancer Group study ALL-201537
Sufficient vitamin D is favorable for children with persistent and chronic immune thrombocytopenia36
Renin-angiotensin inhibitors reduce thrombotic complications in Essential Thrombocythemia and Polycythemia Vera patients with arterial hypertension35
Impact of race and ethnicity on outcomes after autologous stem cell transplantation for patients with newly diagnosed multiple myeloma34
Intramural esophageal hematoma precipitated by acquired factor XI deficiency in a patient with relapsed T cell prolymphocytic leukemia after allogeneic hematopoietic cell transplantation31
Genetic variability profiling of the p53 signaling pathway in chronic lymphocytic leukemia. Individual and combined analysis of TP53, MDM2 and NQO1 gene variants30
Advances in the ocular complications after hematopoietic stem cell transplantation29
The presence of idiopathic thrombocytopenic purpura and incidence of acute non-ST elevation myocardial infarction29
CML in the very elderly: the impact of comorbidities and TKI selection in a real-life multicenter study28
Clonal evolution analysis of a rare acute promyelocytic leukemia patient transforming from essential thrombocythemia27
CAG (cytarabine, aclarubicin and granulocyte colony-stimulating factor) regimen for core binding factor acute myeloid leukaemia with measurable residual disease26
Risk factors and outcome of Stenotrophomonas maltophilia infection after allogeneic hematopoietic stem cell transplantation: JSTCT, Transplant Complications Working Group26
Maternal factors associated with iron deficiency without anaemia in early pregnancy: ECLIPSES study25
Stem cell mobilization in multiple myeloma: challenges, strategies, and current developments23
Coefficient of variation and texture analysis of 18F-FDG PET/CT images for the prediction of outcome in patients with multiple myeloma23
0.11977410316467